Yan Fu

7.2k total citations · 1 hit paper
169 papers, 5.2k citations indexed

About

Yan Fu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yan Fu has authored 169 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 39 papers in Oncology and 32 papers in Cancer Research. Recurrent topics in Yan Fu's work include Angiogenesis and VEGF in Cancer (25 papers), Cancer, Hypoxia, and Metabolism (16 papers) and Heat shock proteins research (11 papers). Yan Fu is often cited by papers focused on Angiogenesis and VEGF in Cancer (25 papers), Cancer, Hypoxia, and Metabolism (16 papers) and Heat shock proteins research (11 papers). Yan Fu collaborates with scholars based in China, United States and Canada. Yan Fu's co-authors include Yongzhang Luo, Xiaomin Song, Yongzhang Luo, Hubing Shi, Nan Song, Xiaofeng Wang, Wei Zhuo, Yujie Huang, Qiongzhu Dong and Lun–Xiu Qin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Yan Fu

160 papers receiving 5.2k citations

Hit Papers

Isolation and characterization of exosomes for cancer res... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Fu China 40 3.2k 1.4k 964 538 448 169 5.2k
Peng Guo China 42 3.3k 1.0× 1.2k 0.9× 1.0k 1.0× 1000 1.9× 436 1.0× 144 5.7k
Santanu Dasgupta United States 41 4.0k 1.2× 958 0.7× 781 0.8× 435 0.8× 379 0.8× 169 6.3k
Ming‐Liang He China 51 4.1k 1.3× 2.0k 1.4× 757 0.8× 587 1.1× 319 0.7× 202 7.9k
Tao Tao China 36 3.4k 1.0× 1.1k 0.8× 509 0.5× 464 0.9× 414 0.9× 189 5.6k
Guosheng Ren China 41 3.6k 1.1× 1.9k 1.3× 1.7k 1.8× 716 1.3× 671 1.5× 188 6.4k
Peng Wang China 40 3.5k 1.1× 1.2k 0.8× 1.0k 1.1× 1.1k 2.1× 427 1.0× 219 5.9k
Tsai‐Ching Hsu Taiwan 44 3.2k 1.0× 1.3k 0.9× 863 0.9× 446 0.8× 487 1.1× 238 6.7k
Daniel E. Gómez Argentina 37 2.6k 0.8× 1.9k 1.3× 1.4k 1.5× 631 1.2× 510 1.1× 130 5.9k
Thomas Klonisch Canada 46 3.0k 0.9× 1.1k 0.8× 892 0.9× 929 1.7× 507 1.1× 180 7.1k
Jinhua Zhang China 37 3.5k 1.1× 1.1k 0.8× 1.1k 1.1× 1.2k 2.2× 480 1.1× 193 6.6k

Countries citing papers authored by Yan Fu

Since Specialization
Citations

This map shows the geographic impact of Yan Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Fu more than expected).

Fields of papers citing papers by Yan Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Fu. The network helps show where Yan Fu may publish in the future.

Co-authorship network of co-authors of Yan Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Fu. A scholar is included among the top collaborators of Yan Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Fu. Yan Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hao, Jian, Yan Fu, Xiaoyang Liu, et al.. (2024). Genetic Association of Juvenile Idiopathic Arthritis With Adult Rheumatic Disease. JAMA Network Open. 7(12). e2451341–e2451341. 1 indexed citations
2.
Wang, Shun, Yan Zheng, Da Xu, et al.. (2024). Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma. Cell Reports Medicine. 5(2). 101415–101415. 42 indexed citations
3.
Fu, Yan, et al.. (2023). The lung-gut crosstalk in respiratory and inflammatory bowel disease. Frontiers in Cellular and Infection Microbiology. 13. 1218565–1218565. 19 indexed citations
4.
Fu, Yan, et al.. (2023). Effect of vitamin K on improving post‑kidney transplant outcomes: a meta‑analysis. Experimental and Therapeutic Medicine. 27(1). 30–30. 3 indexed citations
5.
Liu, Hongyi, et al.. (2023). Young and undamaged recombinant albumin alleviates T2DM by improving hepatic glycolysis through EGFR and protecting islet β cells in mice. Journal of Translational Medicine. 21(1). 89–89. 8 indexed citations
6.
Hu, Beiyuan, Tiantian Zou, Wei Qin, et al.. (2022). Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma. Cancer Research. 82(20). 3845–3857. 104 indexed citations
7.
Fu, Yan, et al.. (2022). CHRNA5 Contributes to Hepatocellular Carcinoma Progression by Regulating YAP Activity. Pharmaceutics. 14(2). 275–275. 11 indexed citations
8.
Li, Xiaokang, Qi Gong, Yan Fu, et al.. (2021). The novel therapeutic strategy of vilazodone-donepezil chimeras as potent triple-target ligands for the potential treatment of Alzheimer's disease with comorbid depression. European Journal of Medicinal Chemistry. 229. 114045–114045. 13 indexed citations
9.
Du, Peizhun, Cheng’en Hu, Yunyun Qin, et al.. (2019). LncRNA PVT1 Mediates Antiapoptosis and 5-Fluorouracil Resistance via Increasing Bcl2 Expression in Gastric Cancer. Journal of Oncology. 2019. 1–10. 60 indexed citations
10.
Zhao, Jing, Yan Fu, Jing Wu, et al.. (2018). The Diverse Mechanisms of miRNAs and lncRNAs in the Maintenance of Liver Cancer Stem Cells. BioMed Research International. 2018. 1–9. 19 indexed citations
11.
Fu, Yan. (2016). The effect of Heixiaoyao and Shensiwei on tamoxifen-induced climacteric syndrome in patients with breast cancer: a clinical study. 1 indexed citations
12.
Wang, Shan, Xin‐an Lu, Peng Liu, et al.. (2015). Endostatin Has ATPase Activity, Which Mediates Its Antiangiogenic and Antitumor Activities. Molecular Cancer Therapeutics. 14(5). 1192–1201. 23 indexed citations
13.
Qi, Feifei, Ting He, Lin Jia, et al.. (2015). The miR-30 Family Inhibits Pulmonary Vascular Hyperpermeability in the Premetastatic Phase by Direct Targeting of Skp2. Clinical Cancer Research. 21(13). 3071–3080. 31 indexed citations
14.
Guo, Lifang, Xingchao Geng, Yang Chen, et al.. (2014). Pre-clinical toxicokinetics and safety study of M2ES, a PEGylated recombinant human endostatin, in rhesus monkeys. Regulatory Toxicology and Pharmacology. 69(3). 512–523. 10 indexed citations
15.
Zhuo, Wei, Lin Jia, Nan Song, et al.. (2012). The CXCL12–CXCR4 Chemokine Pathway: A Novel Axis Regulates Lymphangiogenesis. Clinical Cancer Research. 18(19). 5387–5398. 95 indexed citations
16.
Song, Xiaomin, Xiaofeng Wang, Wei Zhuo, et al.. (2010). The Regulatory Mechanism of Extracellular Hsp90α on Matrix Metalloproteinase-2 Processing and Tumor Angiogenesis. Journal of Biological Chemistry. 285(51). 40039–40049. 99 indexed citations
17.
Ding, Yanping, Yujie Huang, Nan Song, et al.. (2010). NFAT1 Mediates Placental Growth Factor-Induced Myelomonocytic Cell Recruitment via the Induction of TNF - α. The Journal of Immunology. 184(5). 2593–2601. 23 indexed citations
18.
Wang, Xiaofeng, Xiaomin Song, Wei Zhuo, et al.. (2009). The regulatory mechanism of Hsp90α secretion and its function in tumor malignancy. Proceedings of the National Academy of Sciences. 106(50). 21288–21293. 218 indexed citations
19.
Song, Nan, Yujie Huang, Hubing Shi, et al.. (2009). Overexpression of Platelet-Derived Growth Factor-BB Increases Tumor Pericyte Content via Stromal-Derived Factor-1α/CXCR4 Axis. Cancer Research. 69(15). 6057–6064. 97 indexed citations
20.
Dupuis, Jocelyn, François Harel, Yan Fu, et al.. (2009). Molecular Imaging of Monocrotaline-Induced Pulmonary Vascular Disease with Radiolabeled Linear Adrenomedullin. Journal of Nuclear Medicine. 50(7). 1110–1115. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026